
Dr. Nicole Hunter, head of global WMArchitect single-use solutions, outlines how biopharmaceutical manufacturers and suppliers can take steps to secure a resilient supply of single-use assemblies by including pre-qualified, alternative components in the design stage to avoid regulatory compliance interruptions and long lead times.
Single-use systems have transformed biopharmaceutical manufacturing, offering flexibility and speed in delivering life-saving medicines to patients. However, the COVID-19 pandemic exposed significant vulnerabilities in the supply chain, creating…